Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
14
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
29%
4 trials in Phase 3/4
67%
4 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Taabo Tutoring Study
Role: collaborator
Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire
Role: collaborator
Moxidectin for LF, Cote d'Ivoire (DOLF)
Role: collaborator
Improving Uptake of Antenatal Care Services in Rural Côte d'Ivoire
Role: collaborator
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Role: collaborator
Citizen Action for Sustainable Dengue Control in Sub-Saharan Africa
Role: collaborator
Digital Toolkit for Skin Diseases in LMICs: Part 2
Role: collaborator
Efficacy and Safety of IVM/ALB Co-administration
Role: collaborator
Efficacy and Safety of MOX/ALB Co-administration
Role: collaborator
Albendazole Dose Finding and Pharmacokinetics in Children and Adults
Role: collaborator
Treat Early and Broad: Thermotherapy of Buruli Ulcer Integrated Into WHO-recommended Wound Management in West Africa
Role: collaborator
Digital Toolkit for Skin Diseases in LMICs
Role: collaborator
Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)
Role: collaborator
Strategies to Increase Antenatal Iron and Folic Acid Supplementation and Malaria Prophylaxis
Role: lead
All 14 trials loaded